Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients

被引:50
作者
Butrym, Aleksandra [1 ,2 ]
Rybka, Justyna [1 ]
Baczynska, Dagmara [3 ]
Tukiendorf, Andrzej [4 ]
Kuliczkowski, Kazimierz [1 ]
Mazur, Grzegorz [5 ]
机构
[1] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Pasteur 4 Str, PL-50367 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Physiol, PL-50367 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Forens Med, Mol Tech Unit, PL-50367 Wroclaw, Poland
[4] Canc Ctr Inst Oncol, Dept Epidemiol, Gliwice, Poland
[5] Wroclaw Med Univ, Dept Internal & Occupat Dis & Hypertens, PL-50367 Wroclaw, Poland
关键词
miR-204; Acute myeloid leukemia; Expression; Survival; Prognosis; CANCER; MIGRATION;
D O I
10.1186/s13046-015-0184-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Acute myeloid leukemia (AML) is a heterogeneous neoplasm of the bone marrow with poor prognosis. In clinical practice new prognostic factors are still needed. MicroRNAs (miRs), small endogenous noncoding RNAs, play an essential role in the development and progression of acute leukemia. The aim of the study was to evaluate miR-204 expression in patients with AML at diagnosis and after induction chemotherapy, in comparison to healthy controls. We also investigated, if miR-204 expression correlates with clinical features of AML patients. Methods: miR-204 expression has been analyzed using RT-PCR in 95 bone marrow specimens from newly diagnosed AML patients in comparison to 20 healthy subject. Results: We showed down-regulated miR-204 expression in AML patients, which was associated with shorter patients' survival. Higher expression of miR-204 in patients after induction therapy was correlated with complete remission achieving. Conclusions: We showed low miR-204 expression in AML and found it to be an independent prognostic factor in this patient population.
引用
收藏
页数:5
相关论文
共 24 条
[1]
[Anonymous], BIOMARK MED
[2]
[Anonymous], APPL BAYESIAN MODELL
[3]
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death [J].
Chen, Zhiyu ;
Sangwan, Veena ;
Banerjee, Sulagna ;
Mackenzie, Tiffany ;
Dudeja, Vikas ;
Li, Xiaowu ;
Wang, Huaizhi ;
Vickers, Selwyn M. ;
Saluja, Ashok K. .
MOLECULAR CANCER, 2013, 12
[4]
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].
Cheson, BD ;
Bennett, JM ;
Kopecky, KJ ;
Büchner, T ;
Willman, CL ;
Estey, EH ;
Schiffer, CA ;
Döhner, H ;
Tallman, MS ;
Lister, TA ;
LoCocco, F ;
Willemze, R ;
Biondi, A ;
Hiddemann, W ;
Larson, RA ;
Löwenberg, B ;
Sanz, MA ;
Head, DR ;
Ohno, R ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649
[5]
Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1 [J].
Chung, T. K. H. ;
Lau, T. S. ;
Cheung, T. H. ;
Yim, S. F. ;
Lo, K. W. K. ;
Siu, N. S. S. ;
Chan, L. K. Y. ;
Yu, M. Y. ;
Kwong, J. ;
Doran, G. ;
Barroilhet, L. M. ;
Ng, A. S. W. ;
Wong, R. R. Y. ;
Wang, V. W. ;
Mok, S. C. ;
Smith, D. I. ;
Berkowitz, R. S. ;
Wong, Y. F. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (05) :1036-1045
[6]
COX DR, 1972, J R STAT SOC B, V34, P187
[7]
CME Information: Acute myeloid leukemia: 2014 update on risk-stratification and management [J].
Estey, Elihu H. .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (11) :1063-1081
[8]
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin [J].
Garzon, Ramiro ;
Garofalo, Michela ;
Martelli, Maria Paola ;
Briesewitz, Roger ;
Wang, Lisheng ;
Fernandez-Cymering, Cecilia ;
Volinia, Stefano ;
Liu, Chang-Gong ;
Schnittger, Susanne ;
Haferlach, Torsten ;
Liso, Arcangelo ;
Diverio, Daniela ;
Mancini, Marco ;
Meloni, Giovanna ;
Foa, Robin ;
Martelli, Massimo F. ;
Mecucci, Cristina ;
Croce, Carlo M. ;
Falini, Brunangelo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) :3945-3950
[9]
Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization [J].
Imam, J. Saadi ;
Plyler, Jason R. ;
Bansal, Hima ;
Prajapati, Suresh ;
Bansal, Sanjay ;
Rebeles, Jennifer ;
Chen, Hung-I Harry ;
Chang, Yao-Fu ;
Panneerdoss, Subbarayalu ;
Zoghi, Behyar ;
Buddavarapu, Kalyan C. ;
Broaddus, Russell ;
Hornsby, Peter ;
Tomlinson, Gail ;
Dome, Jeffrey ;
Vadlamudi, Ratna K. ;
Pertsemlidis, Alexander ;
Chen, Yidong ;
Rao, Manjeet K. .
PLOS ONE, 2012, 7 (12)
[10]
Li WD, 2014, INT J CLIN EXP PATHO, V7, P3287